Abstract:Background: Patients with Alzheimer's disease (AD) often exhibit characteristic clinical manifestations, particularly neuropsychiatric symptoms. Previous studies have shown that white matter hyperintensity (WMH) is strongly associated with AD progression, as well as neuropsychiatric symptoms. The purpose of this study was to investigate the clinical and neuropsychological characteristics of AD patients with WMH. Methods: This retrospective study involved 104 18-fluorodeoxyglucose-positron emission computed tomography (18FDG-PET-CT)-defined AD patients treated at Tianjin Huanhu Hospital from January 2010 to December 2022. Cranial magnetic resonance imaging (MRI) provided semi-quantitative data on brain structure and WMH. Collect and analyze patient clinical data. Neuropsychological assessments were used to evaluate cognitive function and psychobehavioral traits. Results: Among the 104 patients, 66 were in the WMH group (63.5%) and 38 in the non-white matter hyperintensity (non-WMH) group (36.5%). There were no significant differences in gender, age, age of onset, education, BMI, smoking, drinking, diabetes, coronary heart disease, dementia family history, fasting blood glucose, total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C) between the two groups. The WMH group showed higher rates of hypertension, homocysteine (Hcy) levels, NPI, and CDR scores as compared to the non-WMH group (p < 0.05). MMSE and MoCA scores were significantly lower in the WMH group (p < 0.05). In the MMSE subitem analysis, patients in the WMH group showed a decrease in attention, recall, and language scores. In the MOCA subitem analysis, WMH patients had lower scores in executive function, naming, attention, language, abstraction, and orientation (p < 0.05). Furthermore, subgroup analysis of NPI showed a higher incidence of delusions, depression, and apathy in the WMH group (p < 0.05). According to the hierarchical analysis of mild, moderate and severe dementia groups, the hypertension, leukoencephalopathy, Hcy level, Fazekas total score, PWMH and DWMH scores in the severe dementia group were significantly higher than those in the mild and moderate dementia groups (p < 0.05). As the disease progresses, more and more patients show increased white matter hyperintensity. Conclusion: White matter lesions are closely correlated with cognitive decline and psychobehavioral symptoms in AD patients, and may be used as an indicator of disease progression. Priority should be given to early screening and prevention of WMH-related risk factors.

Impact of Different White Matter Hyperintensities Patterns on Cognition: A Cross-Sectional and Longitudinal Study.

Severity of White Matter Hyperintensities: Lesion Patterns, Cognition, and Microstructural Changes.

White matter hyperintensity patterns: associations with comorbidities, amyloid, and cognition

Associations of White Matter Hyperintensities with Cognitive Decline: A Longitudinal Study

THE CUMULATIVE SPATIAL DISTRIBUTION OF WHITE MATTER HYPERINTENSITIES AND ITS CRITICAL STAGE THAT AFFECTS COGNITION AND THE BRAIN IN NON-DEMENTED ELDERLY

Topographical differences in white matter hyperintensity burden and cognition in aging, MCI, and AD

Alteration of Regional Homogeneity and White Matter Hyperintensities in Amnestic Mild Cognitive Impairment Subtypes Are Related to Cognition and CSF Biomarkers

Data‐driven approach reveals heterogeneity and region‐specific association of white matter hyperintensities with the APOE genotype

White matter hyperintensity distribution differences in aging and neurodegenerative disease cohorts

White Matter Hyperintensities Predict Cognitive Decline: A Community-Based Study

Association of white matter hyperintensities with cognitive decline and neurodegeneration

Regional white matter hyperintensities: aging, Alzheimer's disease risk, and cognitive function

Abstract P366: High Burden of Tract-Specific White Matter Hyperintensities Relates to Impaired Microstructural Integrity of Distal White Matter Tracts in Community-Dwelling Elders

Differential Influence of Location-Specific White-Matter Hyperintensities on Attention Subdomains Measured Using the Attention Network Test.

Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD

Dysfunctional Architecture Underlies White Matter Hyperintensities with and without Cognitive Impairment

The clinical and neuropsychological profiles of Alzheimer's disease with white matter hyperintensity in North China

Abnormal Cerebrovascular Reactivity and Functional Connectivity Caused by White Matter Hyperintensity Contribute to Cognitive Decline.

Heterogeneity of White Matter Hyperintensities in Cognitively Impaired Patients With Cerebral Small Vessel Disease

Abnormal Cerebral Blood Flow and Functional Connectivity Strength in Subjects With White Matter Hyperintensities

White matter hyperintensity spatial patterns: risk factors and clinical correlates